GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

ETH researchers have developed a new gene switch that can be activated using a commercially available nitroglycerine patch ...

A new study examines how cost, side effects and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

It's most common among people with type 1 diabetes who take medication such as insulin to control their blood glucose. The drugs keep their blood sugar levels in such tight control that they rarely ...

Over about 3.5 years, Al-Aly and his colleagues followed more than 200,000 people with diabetes who were on GLP-1 drugs and about 1.7 million people with diabetes using other blood-sugar-lowering ...